Report
Nikolaas Faes

HEXO SELL | CAD0.1 vs. CAD0.5 Equity holders beware

º Accelerating revenue decline in Q2 to -33% from -10% in Q1.
And the plan is more cost cutting and regaining share.
Tilray to the rescue, really?
Hexo shares are worth not much.
Underlying
Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Nikolaas Faes

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch